Inspire Medical Systems, Inc.

NYSE INSP

Inspire Medical Systems, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2024: USD 755.59 M

Inspire Medical Systems, Inc. Revenue is USD 755.59 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 32.52% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Inspire Medical Systems, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 570.19 M, a 63.68% change year over year.
Inspire Medical Systems, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 348.35 M, a 73.31% change year over year.
Inspire Medical Systems, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 201.00 M, a 108.78% change year over year.
Inspire Medical Systems, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 96.28 M, a 34.27% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

NYSE: INSP

Inspire Medical Systems, Inc.

CEO	Mr. Timothy P. Herbert
IPO Date	May 3, 2018
Location	United States
Headquarters	5500 Wayzata Boulevard
Employees	1,011
Sector	Health Care
Industries Telehealth Pharmaceuticals

Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Key trends

Past 5 years